Solesence Inc
Solesence Inc designs, develops, and sells innovative footwear solutions, primarily targeting the personal products market.
Business. Solesence Inc (SLSN.O) is a personal products company operating within the Consumer Non-Cyclicals sector. The firm generates revenue through the sale of personal care items, though specific operating segments and geographic breakdowns are not disclosed. Headquartered in the United States, the company is primarily listed on the NASDAQ stock exchange.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Solesence Inc (SLSN.O) is a personal products company operating within the Consumer Non-Cyclicals sector. The firm generates revenue through the sale of personal care items, though specific operating segments and geographic breakdowns are not disclosed. Headquartered in the United States, the company is primarily listed on the NASDAQ stock exchange.
Solesence Inc has a market capitalization of $92.53 million and a price-to-earnings ratio of 51.69, indicating a high valuation relative to its earnings. The company's price-to-book ratio is 5.25, suggesting that the market values the company significantly above its book value. The enterprise value to EBITDA ratio is 67.75, which is notably high and may reflect investor expectations of future earnings growth or market sentiment. The company's liquidity position is characterized by a current ratio of 2.07, indicating it has sufficient current assets to cover its current liabilities. However, the operating cash flow is negative at -$8.57 million, which could signal short-term liquidity challenges.
In terms of profitability, Solesence Inc has a return on equity of 10.15% and a return on assets of 3.58%, which are both below the industry median for the Personal Products sector. The company's gross profit margin is 25.88%, and its operating margin is 2.53%, both of which are lower than the industry median. These figures suggest that the company is not as efficient in converting revenue into profit as its peers. The net income margin is 0.29%, which is also below the industry median, indicating that the company is struggling to maintain profitability relative to its revenue.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification could expose the company to higher risk if demand in its primary market declines. The absence of segment or geographic breakdowns in the financial data limits the ability to assess the company's exposure to different markets or product lines.
Solesence Inc's growth trajectory is uncertain, as the available data does not provide specific revenue growth rates or future projections. The company's capital expenditure of -$2.14 million indicates a reduction in investment in long-term assets, which could signal a strategic shift or financial constraints. The free cash flow of $544,000 is positive but relatively small, which may limit the company's ability to reinvest in growth opportunities or pay dividends.
The company faces several risk factors, including a medium liquidity risk due to its negative operating cash flow and a debt-to-equity ratio of 0.87. The risk assessment also notes that net cash is negative after subtracting total debt, which could lead to financial distress if not managed properly. The dilution risk is assessed as low, but the company's capital structure and potential for future dilution should be monitored closely.
Recent events and disclosures do not provide specific details on recent filings or transcripts, but the company's ESG scores indicate moderate social and governance performance. The ESG controversies score of 100.00 suggests that the company has not been involved in any significant controversies, which is a positive sign for its governance and social responsibility practices.
- Solesence Inc is significantly overvalued based on its price-to-earnings and enterprise value to EBITDA ratios.
- The company's profitability metrics, including return on equity and operating margin, are below industry medians.
- The company's revenue is not diversified across segments or geographies, increasing its exposure to market-specific risks.
- The company's liquidity position is weak, with a negative operating cash flow and a debt-to-equity ratio of 0.87.
- The company's ESG scores suggest moderate social and governance performance with no significant controversies.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Solesence Inc Market data — financials · 2026-05-29
- Solesence Inc Market data — ESG · 2026-05-29
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2025-12-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
Leadership
- Kevin CuretonPresident, Chief Executive Officer, Director
Insider activity
- Director · Common StockBought 1 500 @ $1,91$3K · 2025-12-24
- Director · Common StockBought 1 000 @ $1,92$2K · 2025-12-24
- Director · Common StockBought 5 000 @ $1,95$10K · 2025-11-19
- Director · Common StockBought 5 000 @ $1,89$9K · 2025-11-19
- Director · Common StockBought 267 @ $1,83$489 · 2025-11-18
- Director · Common StockBought 5 000 @ $1,87$9K · 2025-11-17
- Director · Common StockBought 19 789 @ $1,73$34K · 2025-11-14
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): -8.6%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -534.7%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): 6.6%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -57.1%Derived (calculated)
- Net margin (FY 2025-12-31): 2.9%Derived (calculated)
- Gross margin (FY 2025-12-31): 25.9%Derived (calculated)
- Return on equity (FY 2025-12-31): 10.2%Derived (calculated)
- Return on assets (FY 2025-12-31): 3.6%Derived (calculated)
- Current ratio (FY 2025-12-31): 2.07xDerived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 18.6%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -57.7%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -71.4%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 27.2%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): -69.4%Derived (calculated)
- Gross profit (YoY) (2025-12-31 vs 2024-12-31): -0.8%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 18.0%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 0.1%Derived (calculated)
- Current assets (annual): USD 28.78MSEC XBRL filing
- Current liabilities (annual): USD 13.93MSEC XBRL filing
- Total assets (annual): USD 50.05MSEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES 0SEC XBRL filing
- Operating income (annual): USD 1.57MSEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES 0SEC XBRL filing
- Gross profit (annual): USD 16.06MSEC XBRL filing